ABCB1 and brain neoplasm: Another target to take advantage of to enhance the anti-tumor efficacy of TMZ is the p-glycoprotein, referred to as multidrug resistance receptor (MDR1), a transmembrane protein which act as an efflux pump and confer multidrug resistance in brain tumor.